Dr. David R Spriggs MD
Oncologist | Medical Oncology
1275 York Ave New York NY, 10021About
As a medical oncologist and the leader of Memorial Sloan Kettering’s Division of Solid Tumors, I have two principal responsibilities: to manage gynecologic malignancies (predominantly ...
Education and Training
Univ of Wi Med Sch, Madison Wi 1977
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial.
- Primary intravenous paclitaxel and platinum chemotherapy for high-risk Stage I epithelial ovarian carcinoma.
- Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812).
- Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look.
- Complications associated with intraperitoneal chemotherapy catheters.
- The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients.
- Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy.
- Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: application toward a dynamic disease state model of ovarian cancer.
- Ovarian cancer as a chronic disease: a new treatment paradigm. Highlights of a roundtable discussion.
- New drugs in gynecologic cancer.
- Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.
- A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies.
- Taxol administered as a 120 hour infusion.
- Platinum retreatment of platinum-resistant ovarian cancer after nonplatinum therapy.
- Non-kinase second-messenger signaling: new pathways with new promise.
Fellowships
- Harvard Medical School
Dr. David R Spriggs MD's Practice location
Dr. David R Spriggs MD's reviews
Write ReviewPatient Experience with Dr. Spriggs
Recommended Articles
- What Specialist Conducts Chemotherapy?
Chemotherapy is a very delicate and complicated procedure. This is because it also has the ability to cause further complications in a person’s health while it is being used to treat another medical condition. Chemotherapy usually has side effects that can be very severe.Therefore it requires well...
- Wigs During Cancer Treatment: To Wear or Not To Wear?
Many cancer patients have to go through round after round of chemotherapy treatment during their recovery program. One of the most common side effects of the radiation is loss of hair, especially on the head. This can potentially lead to a lot of issues for cancer patients in terms of their...
- The Link Between Foods and Cancer in Women
Findings of a study on the relationship between a high-fat diet and cancer was published in the August 12, 2017 edition of the Journal of the Academy of Nutrition and Dietetics.Lead researcher was Cynthia Thompson, a professor at the University of Arizona’s Zuckerman College of Public Health.Not...
- What are the Signs and Symptoms of Pancreatic Cancer?
Do you want to know the signs and symptoms of pancreatic cancer? Symptoms of this disease typically depend on the location of the cancer. Please note that those who have pancreatic cancer typically see their symptoms manifest only after the cancer grows beyond the pancreas itself. This makes it a...
- Speaking with Your Doctor about Ovarian Cancer Diagnosis and Treatment
The best course of action to beat any cancer is to be as informed, proactive, and honest with your professional cancer care team as you can. They will all be more than willing to answer any questions you might have, but will be able to help you the most when you have done some of the research on...
- $5.8 Million Grant Given to Develop New Immunotherapy for Ovarian Cancer
Ovarian cancer cells can be extremely tricky to get rid of, which makes treatment often expensive and prolonged. Researchers at the University of California San Diego recently received a 5.8-million-dollar grant from the state to develop a new form of immunotherapy for ovarian cancer.The StudyThe...
Nearby Providers
- Dr. Donna McNamara MD92 2nd Street Hackensack NJ 07601
- Howard W. Bruckner2330 Eastchester Rd Bronx New York 10469
- Dr. William H. Nealon M.D.450 Lakeville Road New Hyde Park NY 11042
- Dr. Trevor Joseph Layne MD354 MAIN ST WEST ORANGE NJ 07052
- Rachel Beth Wellner1185 Park Ave New York NY 10128
- Orestes Sanchez703 Main St Paterson New Jersey 07503